Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
DSGN
— Design Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2023 Earnings Call Summary
MAR 19, 2024
REVENUE
$0
EPS
-$0.21
+25.0%
FREE CASH FLOW
-$12.8M
+12.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →